[1]
|
Asamoah, F., Kakourou, A., Dhami, S., et al. (2017) Allergen Immunotherapy for Allergic Asthma: A Systematic Over-view of Systematic Reviews. Clinical and Translational Allergy, 7, Article No. 25.
https://doi.org/10.1186/s13601-017-0160-0
|
[2]
|
Arabkhazaeli, A., Vijverberg, S.J.H., Von Erp, F.C., Raaijmakers, J.A.M., van der Ent, C.K. and van der Zee, A.H.M. (2015) Characteristics and Severity of Asthma in Children with and without Atopic Conditions: A Cross-Sectional Study. BMC Pediatrics, 15, Article No. 172. https://doi.org/10.1186/s12887-015-0481-x
|
[3]
|
Tran, T.N., Zeiger, R.S., Peters, S.P., et al. (2016) Overlap of Atopic, Eosinophilic, and TH2-High Asthma Phenotypes in a General Population with Current Asthma. Annals of Allergy, Asthma & Immunology, 116, 37-42.
https://doi.org/10.1016/j.anai.2015.10.027
|
[4]
|
Durham, S.R., Emminger, W., Kapp, A., et al. (2012) SQ-Standardized Sublingual Grass Immunotherapy: Confirmation of Disease Modification 2 Years after 3 Years of Treatment in a Randomized Trial. Journal of Allergy and Clinical Immunology, 129, 717-725. https://doi.org/10.1016/j.jaci.2011.12.973
|
[5]
|
Durham, S.R., Walker, S.M., Varga, E.M., et al. (1999) Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy. New England Journal of Medicine, 341, 468-475. https://doi.org/10.1056/NEJM199908123410702
|
[6]
|
Noon, L. (1953) Prophylactic Inoculation against Hay Fever. International Archives of Allergy and Immunology, 4, 285-288. https://doi.org/10.1159/000228032
|
[7]
|
James, L.K., Shamji, M.H., Walker, S.M., et al. (2011) Long-Term Tolerance after Allergen Immunotherapy Is Accompanied by selective Persistence of Blocking Antibodies. Journal of Allergy and Clinical Immunology, 127, 509-516.
https://doi.org/10.1016/j.jaci.2010.12.1080
|
[8]
|
Kucuksezer, U.C., Ozdemir, C., Cevhertas, L., Ogulur, I., Akdis, M. and Akdis, C.A. (2020) Mechanisms of Allergen-Specific Immunotherapy and Allergen Tolerance. Allergology In-ternational, 69, 549-560.
https://doi.org/10.1016/j.alit.2020.08.002
|
[9]
|
Golebski, K., Layhadi, J.A., Sahiner, U., et al. (2021) Induction of IL-10-Producing Type 2 Innate Lymphoid Cells by Allergen Immunotherapy Is Associated with Clinical Response. Im-munity, 54, 291-307.
https://doi.org/10.1016/j.immuni.2020.12.013
|
[10]
|
Eljaszewicz, A., Ruchti, F., Radzikowska, U., et al. (2021) Trained Immunity and Tolerance in Innate Lymphoid Cells, Monocytes, and Dendritic Cells during Allergen-Specific Immunotherapy. Journal of Allergy and Clinical Immunology, 147, 1865-1877. https://doi.org/10.1016/j.jaci.2020.08.042
|
[11]
|
Burks, A.W., Calderon, M.A., Casale, T., et al. (2013) Update on Allergy Immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL Consensus Report. Journal of Allergy and Clinical Immunology, 131, 1288-1296. https://doi.org/10.1016/j.jaci.2013.01.049
|
[12]
|
Canonica, G.W., Cox, L., Pawankar, R., et al. (2014) Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update. World Allergy Organization Journal, 7, Arti-cle No. 6. https://doi.org/10.1186/1939-4551-7-6
|
[13]
|
Agache, I., Lau, S., Akdis, C.A., et al. (2019) EAACI Guidelines on Allergen Immunotherapy: House Dust Mite-Driven Allergic Asthma. Allergy, 74, 855-873. https://doi.org/10.1111/all.13749
|
[14]
|
Yukselen, A., Kendirli, S.G., Yilmaz, M., Altintas, D.U. and Karakoc, G.B. (2012) Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Chil-dren with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study. International Archives of Allergy and Immunology, 157, 288-298. https://doi.org/10.1159/000327566
|
[15]
|
Senti, G., Frei-burghaus, A. U., Larenas-Linnemann, D., et al. (2019) Intralymphatic Immunotherapy: Update and Unmet Needs. Inter-national Archives of Allergy and Immunology, 178, 141-149. https://doi.org/10.1159/000493647
|
[16]
|
Konradsen, J. R., Grundström, J., Hellkvist, L., et al. (2020) Intralymphatic Immunotherapy in Pollen-Allergic Young Adults with Rhinoconjunctivitis and Mild Asthma: A Randomized Trial. Journal of Allergy and Clinical Immunology, 145, 1005-1007. https://doi.org/10.1016/j.jaci.2019.11.017
|
[17]
|
Głobińska, A., Boonpiyathad, T., Satitsuksanoa, P., et al. (2018) Mechanisms of Allergen-Specific Immunotherapy: Diverse Mechanisms of Immune Tolerance to Allergens. Annals of Allergy, Asthma & Immunology, 121, 306-312.
https://doi.org/10.1016/j.anai.2018.06.026
|
[18]
|
Canonica, G.W., Baena-Cagnani, C.E., Bousquet, J., et al. (2007) Recommendations for Standardization of Clinical Trials with Allergen Specific Immunotherapy for Respiratory Allergy. A Statement of a World Allergy Organization (WAO) Taskforce. Allergy, 62, 317-324. https://doi.org/10.1111/j.1398-9995.2006.01312.x
|
[19]
|
向莉, 赵京, 鲍一笑, 等. 儿童气道过敏性疾病螨特异性免疫治疗专家共识[J]. 中华实用儿科临床杂志, 2018, 33(16): 1215-1223.
|
[20]
|
Dinakar, C., Chipps, B.E., et al. (2017) Clinical Tools to Assess Asthma Control in Children. Pediatrics, 139, e20163438.
https://doi.org/10.1542/peds.2016-3438
|
[21]
|
Rodinkova, V., Yuriev, S.D., Kryvopustova, M.V., et al. (2022) Mo-lecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Im-munotherapy. Frontiers in Immunology, 13, Article 848616. https://doi.org/10.3389/fimmu.2022.848616
|
[22]
|
Diamant, Z., Vijverberg, S., Alving, K., et al. (2019) Toward Clinically Applicable Biomarkers for Asthma: An EAACI Position Paper. Allergy, 74, 1835-1851. https://doi.org/10.1111/all.13806
|
[23]
|
Passalacqua, G., Compalati, E. and Canonica, G.W. (2010) Sublingual Im-munotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organization Journal, 3, 216-219.
https://doi.org/10.1097/WOX.0b013e3181e8d19c
|
[24]
|
Passalacqua, G., Bagnasco, D. and Canonica, G.W. (2020) 30 Years of Sublingual Immunotherapy. Allergy, 75, 1107- 1120. https://doi.org/10.1111/all.14113
|
[25]
|
Pitsios, C., Demoly, P., Bilò, M. B., et al. (2015) Clinical Contraindications to Allergen Immunotherapy: An EAACI Position Paper. Allergy, 70, 897-909. https://doi.org/10.1111/all.12638
|
[26]
|
(1993) 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults. JAMA, 269, Article No. 460. https://doi.org/10.1001/jama.1993.03500040022009
|
[27]
|
Dhami, S., Kakourou, A., Asamoah, F., et al. (2017) Allergen Immunotherapy for Allergic Asthma: A Systematic Review and Meta-Analysis. Allergy, 72, 1825-1848. https://doi.org/10.1111/all.13208
|
[28]
|
de Vos, G., Viswanathan, S., Pichardo, Y., et al. (2021) A Randomized Trial of Subcutaneous Allergy Immunotherapy in Inner-City Children with Asthma Less than 4 Years of Age. Annals of Al-lergy, Asthma & Immunology, 126, 367-377.
https://doi.org/10.1016/j.anai.2020.12.016
|
[29]
|
Demoly, P., Corren, J., Creticos, P., et al. (2021) A 300 IR Sub-lingual Tablet Is an Effective, Safe Treatment for House Dust Mite-Induced Allergic Rhinitis: An International, Dou-ble-Blind, Placebo-Controlled, Randomized Phase III Clinical Trial. Journal of Allergy and Clinical Immunology, 147, 1020-1030. https://doi.org/10.1016/j.jaci.2020.07.036
|
[30]
|
Tanaka, A., Tohda, Y., Okamiya, K., et al. (2020) Effi-cacy and Safety of HDM SLIT Tablet in Japanese Adults with Allergic Asthma. The Journal of Allergy and Clinical Immunology: In Practice, 8, 710-720.
https://doi.org/10.1016/j.jaip.2019.09.002
|
[31]
|
Chaker, A.M., Shamji, M.H., Dumitru, F.A., et al. (2016) Short-Term Subcutaneous Grass Pollen Immunotherapy under the Umbrella of Anti-IL-4: A Randomized Controlled Tri-al. Journal of Allergy and Clinical Immunology, 137, 452-461. https://doi.org/10.1016/j.jaci.2015.08.046
|
[32]
|
Park, H.J., Kim, S.H., Shin, Y.S., et al. (2021) Intralymphatic Immunotherapy with Tyrosine-Adsorbed Allergens: A Dou-ble-Blind, Placebo-Controlled Trial. Respiratory Research, 22, Article No. 170.
https://doi.org/10.1186/s12931-021-01766-0
|
[33]
|
Baba, S.M., Rasool, R., Gull, A., et al. (2021) Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study from Kashmir. Frontiers in Immunology, 12, Article 723814. https://doi.org/10.3389/fimmu.2021.723814
|
[34]
|
Rondón, C., Blanca-López, N., Campo, P., et al. (2018) Specific Immunotherapy in Local Allergic Rhinitis: A Randomized, Double-Blind Placebo-Controlled Trial with Phleum pratense Subcutaneous Allergen Immunotherapy. Allergy, 73, 905-915. https://doi.org/10.1111/all.13350
|
[35]
|
Abrams, E.M. and Szefler, S.J. (2020) Managing Asthma during Coronavirus Disease-2019: An Example for Other Chronic Conditions in Children and Adolescents. Journal of Pediatrics, 222, 221-226.
https://doi.org/10.1016/j.jpeds.2020.04.049
|
[36]
|
Castro-Rodriguez, J.A. and Forno, E. (2020) Asthma and COVID-19 in Children: A Systematic Review and Call for Data. Pediatric Pulmonology, 55, 2412-2418. https://doi.org/10.1002/ppul.24909
|
[37]
|
Wark, P.A.B., Ramsahai, J.M., Pathinayake, P., Malik, B. and Bartlett, N.W. (2018) Respiratory Viruses and Asthma. Seminars in Respiratory and Critical Care Medicine, 39, 45-55. https://doi.org/10.1055/s-0037-1617412
|
[38]
|
Skevaki, C., Karsonova, A., Karaulov, A., Xie, M. and Renz, H. (2020) Asthma-Associated Risk for COVID-19 Development. Journal of Allergy and Clinical Immunology, 146, 1295-1301. https://doi.org/10.1016/j.jaci.2020.09.017
|
[39]
|
Klimek, L., Jutel, M., Akdis, C., et al. (2020) Handling of Allergen Immunotherapy in the COVID-19 Pandemic: An ARIA-EAACI Statement. Allergy, 75, 1546-1554. https://doi.org/10.1111/all.14336
|
[40]
|
Farraia, M., Paciência, I., Castro Mendes, F., et al. (2022) Allergen Immu-notherapy for Asthma Prevention: A Systematic Review and Meta-Analysis of Randomized and Non-Randomized Con-trolled Studies. Allergy, 77, 1719-1735.
https://doi.org/10.1111/all.15295
|
[41]
|
Beigh, A.H., Rasool, R., Kawoosa, F., et al. (2021) Improved Pulmonary Function Test (PFT) after 1 One Year of Sublingual Immunotherapy (SLIT) in Unison with Pharmacotherapy in Mild Allergic Asthmatics. Immunology Letters, 230, 36-41. https://doi.org/10.1016/j.imlet.2020.12.004
|
[42]
|
Nadir Bahceciler, N., Galip, N. and Babayigit, A. (2017) Steroid Sparing Effect of Sublingual Immunotherapy: Real Life Study in Mono/Polisensitized Children with Asthma. Immunotherapy, 9, 1263-1269.
https://doi.org/10.2217/imt-2017-0110
|
[43]
|
Parra-Padilla, D., Zakzuk, J., Carrasquilla, M., et al. (2021) Cost-Effectiveness of the Subcutaneous House Dust Mite Allergen Immunotherapy plus Pharmacotherapy for Allergic Asthma: A Mathematical Model. Allergy, 76, 2229-2233.
https://doi.org/10.1111/all.14723
|
[44]
|
Biddiscombe, M.F. and Usmani, O.S. (2021) Delivery and Adherence with Inhaled Therapy in Asthma. Minerva Medica, 112, 564-572. https://doi.org/10.23736/S0026-4806.20.07276-6
|